Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 5/10

vs
industry
vs
history
Cash-to-Debt 0.63
WMGI's Cash-to-Debt is ranked lower than
87% of the 330 Companies
in the Global Medical Devices industry.

( Industry Median: 2.32 vs. WMGI: 0.63 )
Ranked among companies with meaningful Cash-to-Debt only.
WMGI' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.15  Med: 0.38 Max: 1.53
Current: 0.63
0.15
1.53
Equity-to-Asset 0.34
WMGI's Equity-to-Asset is ranked lower than
90% of the 309 Companies
in the Global Medical Devices industry.

( Industry Median: 0.63 vs. WMGI: 0.34 )
Ranked among companies with meaningful Equity-to-Asset only.
WMGI' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.24  Med: 0.62 Max: 0.79
Current: 0.34
0.24
0.79
Debt-to-Equity 1.15
WMGI's Debt-to-Equity is ranked lower than
93% of the 220 Companies
in the Global Medical Devices industry.

( Industry Median: 0.30 vs. WMGI: 1.15 )
Ranked among companies with meaningful Debt-to-Equity only.
WMGI' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.1  Med: 0.28 Max: 1.94
Current: 1.15
0.1
1.94
Debt-to-EBITDA 12.37
WMGI's Debt-to-EBITDA is ranked lower than
94% of the 158 Companies
in the Global Medical Devices industry.

( Industry Median: 1.98 vs. WMGI: 12.37 )
Ranked among companies with meaningful Debt-to-EBITDA only.
WMGI' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -22.01  Med: -3.95 Max: 93.35
Current: 12.37
-22.01
93.35
Interest Coverage 0.07
WMGI's Interest Coverage is ranked lower than
99.99% of the 212 Companies
in the Global Medical Devices industry.

( Industry Median: 66.37 vs. WMGI: 0.07 )
Ranked among companies with meaningful Interest Coverage only.
WMGI' s Interest Coverage Range Over the Past 10 Years
Min: 0  Med: 0 Max: 0.07
Current: 0.07
0
0.07
Piotroski F-Score: 5
Altman Z-Score: 0.73
Beneish M-Score: -2.44
WACC vs ROIC
8.22%
0.34%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 5/10

vs
industry
vs
history
Operating Margin % 0.68
WMGI's Operating Margin % is ranked lower than
58% of the 312 Companies
in the Global Medical Devices industry.

( Industry Median: 1.96 vs. WMGI: 0.68 )
Ranked among companies with meaningful Operating Margin % only.
WMGI' s Operating Margin % Range Over the Past 10 Years
Min: -46.57  Med: -13.79 Max: 0.68
Current: 0.68
-46.57
0.68
Net Margin % -13.07
WMGI's Net Margin % is ranked lower than
69% of the 312 Companies
in the Global Medical Devices industry.

( Industry Median: 1.40 vs. WMGI: -13.07 )
Ranked among companies with meaningful Net Margin % only.
WMGI' s Net Margin % Range Over the Past 10 Years
Min: -113.05  Med: -27.15 Max: -7.84
Current: -13.07
-113.05
-7.84
ROE % -16.47
WMGI's ROE % is ranked lower than
71% of the 304 Companies
in the Global Medical Devices industry.

( Industry Median: 0.95 vs. WMGI: -16.47 )
Ranked among companies with meaningful ROE % only.
WMGI' s ROE % Range Over the Past 10 Years
Min: -64.55  Med: -28 Max: -5.19
Current: -16.47
-64.55
-5.19
ROA % -4.57
WMGI's ROA % is ranked lower than
61% of the 332 Companies
in the Global Medical Devices industry.

( Industry Median: -0.26 vs. WMGI: -4.57 )
Ranked among companies with meaningful ROA % only.
WMGI' s ROA % Range Over the Past 10 Years
Min: -40.3  Med: -10.07 Max: -3.73
Current: -4.57
-40.3
-3.73
ROC (Joel Greenblatt) % 2.02
WMGI's ROC (Joel Greenblatt) % is ranked lower than
58% of the 327 Companies
in the Global Medical Devices industry.

( Industry Median: 3.87 vs. WMGI: 2.02 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
WMGI' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -66.87  Med: -27.95 Max: 2.02
Current: 2.02
-66.87
2.02
3-Year Revenue Growth Rate 7.00
WMGI's 3-Year Revenue Growth Rate is ranked higher than
57% of the 254 Companies
in the Global Medical Devices industry.

( Industry Median: 4.30 vs. WMGI: 7.00 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
WMGI' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -14.9  Med: -3.3 Max: 10
Current: 7
-14.9
10
3-Year EPS without NRI Growth Rate 49.10
WMGI's 3-Year EPS without NRI Growth Rate is ranked higher than
90% of the 223 Companies
in the Global Medical Devices industry.

( Industry Median: 7.80 vs. WMGI: 49.10 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
WMGI' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -89.2  Med: 19.6 Max: 49.1
Current: 49.1
-89.2
49.1
GuruFocus has detected 5 Warning Signs with Wright Medical Group NV WMGI.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» WMGI's 30-Y Financials

Financials (Next Earnings Date: 2019-02-21 Est.)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q4 2017

WMGI Guru Trades in Q4 2017

Mario Gabelli 217,519 sh (unchged)
Eaton Vance Worldwide Health Sciences Fund 588,290 sh (unchged)
Steven Cohen Sold Out
Ken Fisher 2,843,217 sh (-1.65%)
Jim Simons 39,207 sh (-87.12%)
» More
Q1 2018

WMGI Guru Trades in Q1 2018

Jim Simons 805,607 sh (+1954.75%)
Mario Gabelli 217,519 sh (unchged)
Eaton Vance Worldwide Health Sciences Fund 588,290 sh (unchged)
Ken Fisher 2,744,485 sh (-3.47%)
» More
Q2 2018

WMGI Guru Trades in Q2 2018

Steven Cohen 2,967,368 sh (New)
Paul Tudor Jones 34,061 sh (New)
Ken Fisher 2,806,275 sh (+2.25%)
Mario Gabelli 217,519 sh (unchged)
Eaton Vance Worldwide Health Sciences Fund 471,165 sh (-19.91%)
Jim Simons 517,907 sh (-35.71%)
» More
Q3 2018

WMGI Guru Trades in Q3 2018

Pioneer Investments 64,000 sh (New)
Paul Tudor Jones 65,090 sh (+91.10%)
Ken Fisher 2,757,861 sh (-1.73%)
Eaton Vance Worldwide Health Sciences Fund 262,871 sh (-44.21%)
Mario Gabelli 183,530 sh (-15.63%)
Jim Simons 365,607 sh (-29.41%)
Steven Cohen 2,239,242 sh (-24.54%)
» More
» Details

Insider Trades

Latest Guru Trades with NAS:WMGI

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

Guru Date Action
Impact Price Range
(Average)*
Change from Average Comment Current Shares
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Wright Medical Group NV does not have enough historical financial data to display Peter Lynch Chart.

Business Description

Industry: Medical Devices » Medical Devices    NAICS: 339113    SIC: 3842
Compare:TSE:7575, XSWX:YPSN, OCSE:OSSR, NAS:CNMD, TSE:8086, TSE:6849, SZSE:300633, TSE:3360, NYSE:ITGR, SZSE:300298, HKSE:00853, XSWX:TECN, SHSE:603387, SZSE:002317, NYSE:NVRO, NAS:NUVA, SHSE:603579, XTAE:MZOR, HKSE:01066, NAS:AXGN » details
Traded in other countries:T98.Germany,
Headquarter Location:Netherlands
Wright Medical Group NV is a medical device company that manufactures & sells extremities and biologics products in USA & internationally. It offers joint implants & bone fusion & fixation devices for shoulder, elbow, wrist, and hand.

Wright Medical Group develops medical devices and products in five categories: lower extremities, upper extremities, biologics, large joints, and sport medicine, and other. Products for lower extremities include joint implants and bone fixation devices for the foot and ankle, whereas products for upper extremities include implants and devices for the shoulder, elbow, wrist, and hand. The biologics business sells products used to treat damaged or diseased bone, tendons, and soft tissues or to stimulate bone growth. The large joints business sells hip and knee replacement implants. The firm's sports medicine products are used to mechanically repair tissue injuries. Wright Medical Group generates the majority of its revenue in the United States.

Guru Investment Theses on Wright Medical Group NV

Keeley Funds Comments on Wright Medical Group - Feb 07, 2018

Wright Medical Group, NV (NASDAQ:WMGI) is a global orthopedic medical device company focused on upper/lower extremities and biologics. The company underperformed as it suffered disruption from a sizable sales force expansion that ultimately resulted in the company reducing earnings guidance. While it is taking much longer for the new sales representatives to reach full productivity, the 50% increase in the size of the salesforce will ultimately be beneficial for the company as it results in accelerating sales and earnings growth.



From the Keeley All Cap Value Fund fourth quarter 2017 shareholder letter.



Check out Keeley Asset Management Corp latest stock trades

Keeley Funds Comments on Wright Medical Group - Aug 14, 2017

Wright Medical Group (NASDAQ:WMGI) is a global medical device company focused on extremities and biologics. The company had exceeded analysts’ estimates for the past four quarters and EBITDA margins have increased from -5.5% in 4Q15 to 11.7% in 4Q16, on its way towards their 20% margin target by 2019. Unfortunately, the company missed first quarter 2017 earnings as a planned salesforce expansion did not lead to increased sales as quickly as hoped. Underlying metrics remain strong and the company should recover as the year proceeds. In addition, a recent Financial Times article reported on speculation that a larger orthopedic company may be looking to acquire Wright. Given the consolidation in the orthopedic market and CEO Palmisano’s history of selling his prior companies, we would not be surprised if a strategic player recognizes Wright’s intrinsic value sooner than expected.



From Keeley All Cap Value Fund second quarter 2017 shareholder commentary.



Check out Keeley Asset Management Corp latest stock trades

Keeley Funds Comments on Wright Medical Group - Apr 27, 2017

Wright Medical Group (NASDAQ:WMGI) is a global medical device company focused on extremities and biologics. The company completed a merger of equals with Tornier NV in late 2015 becoming the worldwide leader in providing surgical solutions for upper extremities (shoulder, elbow, wrist and hands), lower extremities (foot and ankle) and biologics (bone graft stimulators) - three of the fastest growing segments in orthopedics. Both companies had been investing heavily for growth resulting in low, short-term profitability, but under new CEO Robert Palmisano, the combined company has substantial scale opportunities and would be a beneficiary of the aging, but much more active baby boom generation. The company has exceeded analysts’ estimates for the past four quarters post the deal closing and EBITDA margins have increased from -5.5% in 4Q15 to 11.7% in 4Q16, on its way towards our 20% margin target by 2019. In addition, a recent Financial Times article reported on speculation that a larger orthopedic company may be looking to acquire Wright. Given the consolidation in the orthopedic market and CEO Palmisano’s history of selling his prior companies, we would not be surprised if a strategic player recognizes Wright’s intrinsic value sooner than expected.



From the Keeley Small Cap Value Fund first quarter 2017 commentary.



Check out John Keeley latest stock trades

Ratios

vs
industry
vs
history
Forward PE Ratio 93.46
WMGI's Forward PE Ratio is ranked lower than
99.99% of the 52 Companies
in the Global Medical Devices industry.

( Industry Median: 25.06 vs. WMGI: 93.46 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PB Ratio 3.13
WMGI's PB Ratio is ranked lower than
59% of the 310 Companies
in the Global Medical Devices industry.

( Industry Median: 3.06 vs. WMGI: 3.13 )
Ranked among companies with meaningful PB Ratio only.
WMGI' s PB Ratio Range Over the Past 10 Years
Min: 1.47  Med: 2.34 Max: 5.81
Current: 3.13
1.47
5.81
PS Ratio 3.74
WMGI's PS Ratio is ranked higher than
54% of the 294 Companies
in the Global Medical Devices industry.

( Industry Median: 3.15 vs. WMGI: 3.74 )
Ranked among companies with meaningful PS Ratio only.
WMGI' s PS Ratio Range Over the Past 10 Years
Min: 2.22  Med: 3.48 Max: 5.13
Current: 3.74
2.22
5.13
EV-to-EBIT 716.08
WMGI's EV-to-EBIT is ranked lower than
99.99% of the 174 Companies
in the Global Medical Devices industry.

( Industry Median: 24.76 vs. WMGI: 716.08 )
Ranked among companies with meaningful EV-to-EBIT only.
WMGI' s EV-to-EBIT Range Over the Past 10 Years
Min: -1004  Med: -21.2 Max: 742.09
Current: 716.08
-1004
742.09
EV-to-EBITDA 44.41
WMGI's EV-to-EBITDA is ranked lower than
86% of the 188 Companies
in the Global Medical Devices industry.

( Industry Median: 18.14 vs. WMGI: 44.41 )
Ranked among companies with meaningful EV-to-EBITDA only.
WMGI' s EV-to-EBITDA Range Over the Past 10 Years
Min: -304.6  Med: -18.9 Max: 640.7
Current: 44.41
-304.6
640.7
EV-to-Revenue 4.84
WMGI's EV-to-Revenue is ranked lower than
52% of the 309 Companies
in the Global Medical Devices industry.

( Industry Median: 3.73 vs. WMGI: 4.84 )
Ranked among companies with meaningful EV-to-Revenue only.
WMGI' s EV-to-Revenue Range Over the Past 10 Years
Min: 2.3  Med: 4.3 Max: 7.2
Current: 4.84
2.3
7.2
Current Ratio 1.24
WMGI's Current Ratio is ranked lower than
86% of the 324 Companies
in the Global Medical Devices industry.

( Industry Median: 2.71 vs. WMGI: 1.24 )
Ranked among companies with meaningful Current Ratio only.
WMGI' s Current Ratio Range Over the Past 10 Years
Min: 0.95  Med: 2.45 Max: 3.29
Current: 1.24
0.95
3.29
Quick Ratio 1.07
WMGI's Quick Ratio is ranked lower than
82% of the 324 Companies
in the Global Medical Devices industry.

( Industry Median: 2.03 vs. WMGI: 1.07 )
Ranked among companies with meaningful Quick Ratio only.
WMGI' s Quick Ratio Range Over the Past 10 Years
Min: 0.8  Med: 1.47 Max: 1.99
Current: 1.07
0.8
1.99
Days Inventory 354.29
WMGI's Days Inventory is ranked lower than
88% of the 294 Companies
in the Global Medical Devices industry.

( Industry Median: 143.61 vs. WMGI: 354.29 )
Ranked among companies with meaningful Days Inventory only.
WMGI' s Days Inventory Range Over the Past 10 Years
Min: 342.93  Med: 424.23 Max: 530.83
Current: 354.29
342.93
530.83
Days Sales Outstanding 54.86
WMGI's Days Sales Outstanding is ranked higher than
56% of the 276 Companies
in the Global Medical Devices industry.

( Industry Median: 69.21 vs. WMGI: 54.86 )
Ranked among companies with meaningful Days Sales Outstanding only.
WMGI' s Days Sales Outstanding Range Over the Past 10 Years
Min: 54.86  Med: 70.66 Max: 118.01
Current: 54.86
54.86
118.01
Days Payable 92.25
WMGI's Days Payable is ranked higher than
72% of the 261 Companies
in the Global Medical Devices industry.

( Industry Median: 58.34 vs. WMGI: 92.25 )
Ranked among companies with meaningful Days Payable only.
WMGI' s Days Payable Range Over the Past 10 Years
Min: 51.36  Med: 84.7 Max: 156.08
Current: 92.25
51.36
156.08

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio -29.30
WMGI's 3-Year Average Share Buyback Ratio is ranked lower than
81% of the 244 Companies
in the Global Medical Devices industry.

( Industry Median: -5.70 vs. WMGI: -29.30 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
WMGI' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -35  Med: -19.7 Max: -7.6
Current: -29.3
-35
-7.6

Valuation & Return

vs
industry
vs
history
Price-to-Median-PS-Value 1.07
WMGI's Price-to-Median-PS-Value is ranked higher than
69% of the 237 Companies
in the Global Medical Devices industry.

( Industry Median: 1.02 vs. WMGI: 1.07 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
WMGI' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.69  Med: 1.01 Max: 1.34
Current: 1.07
0.69
1.34
Earnings Yield (Greenblatt) % 0.13
WMGI's Earnings Yield (Greenblatt) % is ranked lower than
56% of the 332 Companies
in the Global Medical Devices industry.

( Industry Median: 0.74 vs. WMGI: 0.13 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
WMGI' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: -17.7  Med: -4.6 Max: 0.2
Current: 0.13
-17.7
0.2

More Statistics

Revenue (TTM) (Mil) $815.65
EPS (TTM) $ -0.98
Beta1.33
Volatility37.01%
52-Week Range $19.01 - 30.75
Shares Outstanding (Mil)125.08

Analyst Estimate

Dec18 Dec19
Revenue (Mil $) 827 927
EBIT (Mil $)
EBITDA (Mil $)
EPS ($) -0.12 0.22
EPS without NRI ($) -0.12 0.22
EPS Growth Rate
(Future 3Y To 5Y Estimate)
N/A
Dividends per Share ($)

Piotroski F-Score Details

Piotroski F-Score: 55
Positive ROAN
Positive CFROAN
Higher ROA yoyY
CFROA > ROAY
Lower Leverage yoyY
Higher Current Ratio yoyN
Less Shares Outstanding yoyN
Higher Gross Margin yoyY
Higher Asset Turnover yoyY

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}